Halma has acquired France-based electrosurgical instrument developer Lamidey Noury Medical for €50m ($52.6m).
This strategic move is set to enhance Halma’s healthcare offerings by integrating advanced medical devices that are crucial for minimally invasive surgeries.
Go deeper with GlobalData
With this acquisition, Lamidey Noury will operate as a standalone company within Halma’s healthcare sector, continuing under its current management team.
This underscores Halma’s commitment to advancing healthcare through innovative solutions and strategic growth.
Lamidey Noury’s electrosurgical instruments are claimed to be widely adopted by healthcare professionals worldwide.
They are used during surgeries at the time of cutting tissue and controlling bleeding, which subsequently improves patient outcomes and operational efficiencies.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe acquisition is timely as the demand for specialised medical care increases, driven by an ageing population and a rise in urological and gynaecological diseases among younger individuals.
Halma Group chief executive Marc Ronchetti said: “I am excited to welcome Lamidey Noury to Halma. This acquisition aligns perfectly with our mission of improving patient outcomes.
“Lamidey Noury’s innovative solutions will enhance our portfolio of minimally invasive surgical product capabilities. With Halma’s global reach and resources, we look forward to supporting its development as it continues to scale its business globally.”
The adoption of minimally invasive procedures is increasing, due to their benefits of shorter recovery times and reduced risks.
Electrosurgical instruments are crucial for these procedures, offering precision and control that lead to safer surgeries.
Lamidey Noury Medical president Guillaume Noury said: “Joining Halma is an exciting opportunity for us. Leveraging Halma’s expertise, resources, and global reach will accelerate our growth and innovation.
“We are confident in our ability to continue delivering high-quality surgical tools to our customers worldwide while providing new opportunities for our employees and stakeholders. Together, we will continue improving patient outcomes and driving excellence in healthcare.”
In March, the company acquired Rovers Medical Devices, a company specialising in sample collection devices for cervical cancer prevention and diagnosis, for €85m.
